New Evernorth program to cap out-of-pocket costs for GLP-1s
May 21, 2025 · A 2023 analysis from J.P. Morgan estimates that the market for GLP-1s will exceed $100 billion by 2030. Cigna Evernorth Express Scripts GLP-1 Novo Nordisk Eli Lilly …
Evernorth reaches deals with Novo Nordisk, Eli Lilly to cap GLP-1 ...
May 22, 2025 · Evernorth’s new program caps members’ costs at $200 per month and reduces GLP-1 prices for their plan sponsor. It also includes a simpler prior authorization process and …
Cigna Offers $200 Copay Cap on Weight-Loss Meds for Certain …
May 25, 2025 · Under the new program, insured patients will pay no more than $200 a month for these popular GLP-1 weight-loss meds. That’s right, $200 flat. Sounds great, doesn’t it?
Wegovy and Zepbound costs capped at $200 in new Evernorth …
May 22, 2025 · Novo Nordisk’s Wegovy has a list price of $1,350 per month in the US. Credit: Karen Roach via Shutterstock. Evernorth, the pharmacy benefits unit for health insurer giant …
Cigna Announced a New Agreement for Copay Caps on Eli Lilly and Novo …
May 23, 2025 · The GLP-1 drugs are currently only covered by half of The Cigna Group (NYSE:CI)'s clients. Customers who now provide coverage could save as much as 20%.
Cigna’s Copay Caps Add to Growing Suite of Solutions to GLP-1 …
May 23, 2025 · In an effort to help employers meet the “growing demand” for weight loss medications, The Cigna Group’s Evernorth Health Services on May 21 announced a deal with …
Cigna caps copays on GLP-1 drugs - LinkedIn
May 22, 2025 · Cigna has announced a deal to cap client copays on popular GLP-1 weight loss drugs by Eli Lilly and Novo Nordisk at $200 per month, a sum that would count toward a …
Cigna’s Evernorth caps weight-loss drug copays at $200/month
Cigna’s (NYSE: CI) health services arm, Evernorth, has launched a pharmacy benefit program that caps out-of-pocket costs at $200 per month for patients using the weight-loss drugs - …
Cigna's Evernorth launches Wegovy, Zepbound copayment cap
May 21, 2025 · The company's Evernorth Health Services subsidiary has launched a pharmacy benefit offering that caps monthly copayments for Wegovy and Zepbound, two blockbuster …
Evernorth’s $200 GLP-1 Cap: A Strategic Masterstroke for Cigna in …
May 21, 2025 · By capping monthly costs for Wegovy® and Zepbound® at $200—a fraction of their $1,000+ list prices—Evernorth has engineered a win-win for patients, employers, and …
- Some results have been removed